A single targeted Ets2 allele restricts development of mammary tumors in transgenic mice

Cancer Research

Volumn 59, Issue 17, 1999, Pages 4242-4246

  Neznanov, Nickolay ^a,c   Man, Albert K ^a   Yamamoto, Hideyuki ^a   Hauser, Craig A ^a   Cardiff, Robert D ^b   Oshima, Robert G ^a,c  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST TUMOR; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; MOUSE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TUMOR GROWTH; VIRUS ONCOGENE;

EID: 0033199167     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ghysdael, J., and Boureux, A. The Ets family of transcriptional regulators. In: B. Yaniv and J. Ghysdael (eds.), Oncogenes as Transcriptional Regulators, pp. 29-89, Basel, Switzerland: Birkhauser Verlag, 1997.
2. O'Neill, E. M., Rebay, I., Tijan, R., and Rubin, G. M. The activities of two Ets-related transcription factors required for Drosophila eye development are modulated by the Ras/MAPK pathway. Cell, 78: 137-147, 1994.
3. Yang, B-S., Hauser, C. A., Henkel, G., Colman, M. S., Van Beveren, C., Stacey, K. J., Hume, D. A., Maki, R. A., and Ostrowski, M. C. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activity of c-Ets1 and c-Ets2. Mol. Cell. Biol., 16: 538-547, 1996.
4. McCarthy, S. A., Chen, D., Yang, B-S., Garcia Ramirez, J. J., Cherwinski, H., Chen, X-R., Klagsbrun, M., Hauser, C. A., Ostrowski, M. C., and McMachon, M. Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. Mol. Cell. Biol., 17: 2401-2412, 1997.
5. Galang, C. K., Garcia-Ramirez, J. J., Solski, P. A., Der, C. J., Neznanov, N. N., Oshima, R. G., and Hauser, C. A. Oncogenic neu/ErbB-2 increases Ets, AP-1, and NF-kB-dependent gene expression, and inhibiting Ets activation blocks Neu-mediated cellular transformation. J. Biol. Chem., 271: 7992-7998, 1996.
6. Sapi, E., Flick, M. B., Rodov, S., and Kacinski, B. M. Ets-2 transdominant mutant abolishes anchorage-independent growth and macrophage colony-stimulating factor-stimulated invasion by BT20 breast carcinoma cells. Cancer Res., 58; 1027-1033, 1998.
7. Yamamoto, H., Flannery, M. L., Kupriyanov, S., Pearce, J., McKercher, S. R., Henkel, G. W., Maki, R. A., Werb, Z., and Oshima, R. G. Defective trophoblast function in mice with a targeted mutation of Ets2. Genes Dev., 12: 1315-1326, 1998.
8. Guy, C. T., Cardiff, R. D., and Muller, W. J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol., 12: 954-961, 1992.
9. Guy, C. T., Muthuswamy, S. K., Cardiff, R. D., Soriano, P., and Muller, W. J. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev., 8: 23-32, 1994.
10. Webster, M. A., Hutchinson, J. N., Raug, M. J., Muthuswamy, S. K., Anton, M., Tortorice, C. G., Cardiff, R. D., Graham, F. L., Hassell, J. A., and Muller, W. J. Requirement for both Shc and phosphatidylinositol 3′ kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Mol. Cell. Biol., 18: 2344-2359, 1998.
11. Chomcznski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
12. Sympson, C. J., Talhouk, R. S., Alexander, C. M., Chin, J. R., Clift, S. M., Bissell, M. J., and Werb, Z. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J. Cell Biol., 125: 681-693, 1994.
13. Cardiff, R. D., and Munn, R. J. The histopathology of transgenes and knockouts in the mammary gland. Adv. Oncobiol., 2: 177-202, 1998.
14. Liu, A. Y., Corey, E., Vessella, R. L., Lange, P. H., True, L. D., Huang, G. M., Nelson, P. S., and Hood, L. Identification of differentially expressed prostate genes: increased expression of transcription factor Ets-2 in prostate cancer. Prostate, 30. 145-153, 1997.
15. Sumarsono, S. H., Wilson, T. J., Tymms, M. J., Venter, D. J., Corrick, C. M., Kola, R., Lahoud, M. H., Papas, T. S., Seth, A., and Kola, I. Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice. Nature (Lond.), 379: 534-537, 1996.
16. Rudolph-Owen, L. A., Chan, R., Muller, W. J., and Matrisian, L. M. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis. Cancer Res., 23: 5500-5506, 1998.
17. Coussens, L. M., and Werb, Z. Matrix metalloproteinases and the development of cancer. Chem. Biol., 3: 895-904, 1996.
18. Foos, G., Garcia-Ramirez, J. J., Galang, C. K., and Hauser, C. A. Elevated expression of Ets2 or distinct portions of Ets2 can reverse Ras-mediated cellular transformation. J. Biol. Chem., 273: 18871-18880, 1998.
19. Cheng, A. M., Saxton, T. M., Sakai, R., Kulkarni, S., Mbamalu, G., Vogel, W., Tortorice, C. G., Cardiff, R. D., Cross, J. C., Muller, W. J., and Pawson, T. Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell, 95: 793-803, 1998.
20. Siegel, P. M., Ryan, E. D., Cardiff, R. D., and Muller, W. J. Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. EMBO J., 18: 101-116, 1999.